RJA
FMS icon

Raymond James & Associates’s Fresenius Medical Care FMS Stock Holding History

Raymond James & Associates’s Portfolio FMS Stock Details FMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$349K Sell
16,389
-4,344
-21% -$85.5K ﹤0.01% 3322
2024
Q2 		$396K Buy
20,733
+2,220
+12% +$45.3K ﹤0.01% 3209
2024
Q1 		$357K Sell
18,513
-10,447
-36% -$207K ﹤0.01% 3281
2023
Q4 		$603K Buy
28,960
+1,125
+4% +$21.6K ﹤0.01% 2837
2023
Q3 		$600K Sell
27,835
-2,384
-8% -$57.9K ﹤0.01% 2778
2023
Q2 		$723K Sell
30,219
-105
-0.3% -$2.41K ﹤0.01% 2685
2023
Q1 		$645K Sell
30,324
-10,229
-25% -$196K ﹤0.01% 2761
2022
Q4 		$663K Buy
40,553
+12,638
+45% +$187K ﹤0.01% 2692
2022
Q3 		$392K Sell
27,915
-149
-0.5% -$2.82K ﹤0.01% 3009
2022
Q2 		$700K Sell
28,064
-376
-1% -$11.2K ﹤0.01% 2691
2022
Q1 		$958K Buy
28,440
+7,470
+36% +$246K ﹤0.01% 2627
2021
Q4 		$681K Sell
20,970
-34,851
-62% -$1.15M ﹤0.01% 2873
2021
Q3 		$1.95M Buy
55,821
+8,339
+18% +$326K ﹤0.01% 2119
2021
Q2 		$1.97M Buy
47,482
+36,681
+340% +$1.47M ﹤0.01% 2107
2021
Q1 		$398K Sell
10,801
-5,717
-35% -$216K ﹤0.01% 3174
2020
Q4 		$686K Buy
16,518
+182
+1% +$7.58K ﹤0.01% 2589
2020
Q3 		$694K Sell
16,336
-41,543
-72% -$1.79M ﹤0.01% 2411
2020
Q2 		$2.5M Sell
57,879
-5,706
-9% -$225K ﹤0.01% 1589
2020
Q1 		$2.09M Buy
63,585
+52,428
+470% +$1.95M ﹤0.01% 1544
2019
Q4 		$411K Buy
11,157
+597
+6% +$21.2K ﹤0.01% 2873
2019
Q3 		$355K Sell
10,560
-1,461
-12% -$51.8K ﹤0.01% 2899
2019
Q2 		$472K Buy
12,021
+6,285
+110% +$249K ﹤0.01% 2715
2019
Q1 		$232K Buy
+5,736
New +$214K ﹤0.01% 3141
2018
Q4 		– Sell
-70,026
Closed -$3.6M – 3602
2018
Q3 		$3.6M Buy
70,026
+571
+0.8% +$28.6K 0.01% 1425
2018
Q2 		$3.5M Sell
69,455
-3,378
-5% -$171K 0.01% 1397
2018
Q1 		$3.72M Buy
72,833
+3,389
+5% +$181K 0.01% 1318
2017
Q4 		$3.65M Sell
69,444
-1,708
-2% -$84.9K 0.01% 1311
2017
Q3 		$3.48M Buy
71,152
+63,470
+826% +$3.02M 0.01% 1275
2017
Q2 		$371K Sell
7,682
-9,490
-55% -$437K ﹤0.01% 2591
2017
Q1 		$723K Sell
17,172
-675
-4% -$27.9K ﹤0.01% 2166
2016
Q4 		$753K Buy
17,847
+5,999
+51% +$245K ﹤0.01% 2096
2016
Q3 		$519K Buy
11,848
+2,210
+23% +$98.9K ﹤0.01% 2265
2016
Q2 		$420K Buy
9,638
+465
+5% +$20K ﹤0.01% 2200
2016
Q1 		$404K Buy
+9,173
New +$388K ﹤0.01% 2162

Other funds holding FMS

Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Raymond James & Associates's FMS Position: Q3 2024 in Review

Raymond James & Associates reduced its Fresenius Medical Care (FMS) stake by 21% in Q3 2024, selling an estimated $85.5K and leaving 16,389 shares worth $349K. The position accounts for ﹤0.01% of the portfolio, ranked #3322.

Raymond James & Associates first reported a position in FMS in Q1 2016 and has held it in 34 quarters since. The position peaked at $3.72M in Q1 2018. 167 funds tracked by Wall St. Rank hold FMS as of Q3 2024.

  • Raymond James & Associates held 16,389 shares of Fresenius Medical Care worth $349K as of Q3 2024.
  • Raymond James & Associates sold 4,344 Fresenius Medical Care shares in Q3 2024, an estimated $85.5K.
  • Fresenius Medical Care made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3322 holding.
  • Raymond James & Associates first reported a position in Fresenius Medical Care in Q1 2016 and has held it in 34 quarters since.
  • Raymond James & Associates's Fresenius Medical Care position peaked at $3.72M in Q1 2018.
  • 167 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.